Larsson P T, Schwieler J H, Wallén N H
Department of Clinical Physiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
Blood Coagul Fibrinolysis. 2000 Jan;11(1):61-9.
The present study was undertaken to evaluate the effects of an intravenous infusion of angiotensin II (10 ng/kg per min) on platelet function and coagulation in vivo in 18 healthy males. The infusion increased mean arterial pressure by 23+/-2 mm Hg. Plasma beta-thromboglobulin levels, reflecting platelet secretion, increased by 66+/-24% during the infusion, as did also platelet surface expression of P-selectin as measured by flow cytometry. Platelet fibrinogen binding increased, whereas platelet aggregability, assessed by ex vivo filtragometry, was unaltered. Angiotensin II caused mild activation of the coagulation cascade with increases in plasma levels of thrombin-antithrombin complex and prothrombin fragment F1 + 2. In conclusion, angiotensin II has mild platelet-activating effects in vivo and also enhances coagulation. Markers of platelet secretion are significantly increased, whereas markers of platelet aggregability are less affected. The clinical relevance of these findings remains to be clarified.
本研究旨在评估静脉输注血管紧张素II(每分钟10纳克/千克)对18名健康男性体内血小板功能和凝血的影响。输注使平均动脉压升高了23±2毫米汞柱。反映血小板分泌的血浆β-血小板球蛋白水平在输注期间升高了66±24%,通过流式细胞术测量的血小板表面P-选择素的表达也同样升高。血小板纤维蛋白原结合增加,而通过体外过滤法评估的血小板聚集性未改变。血管紧张素II引起凝血级联的轻度激活,凝血酶-抗凝血酶复合物和凝血酶原片段F1 + 2的血浆水平升高。总之,血管紧张素II在体内具有轻度的血小板激活作用,并且还增强凝血。血小板分泌标志物显著增加,而血小板聚集性标志物受影响较小。这些发现的临床相关性仍有待阐明。